Caitong International Asset Management Co., LTD Pds Biotechnology Corp Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 247 shares of PDSB stock, worth $385. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247
Previous 247
-0.0%
Holding current value
$385
Previous $403,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
61Shares Held
4.26MCall Options Held
163KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$759,6680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA417KShares$650,8580.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA247KShares$385,2840.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il220KShares$343,5350.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $44.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...